Literature DB >> 32108212

Protein labeling approach to improve lysosomal targeting and efficacy of antibody-drug conjugates.

Ying Han1, Yifan Da1, Mingjia Yu2, Yaping Cheng1, Xin Wang1, Jiale Xiong1, Guoying Guo1, Yan Li3, Xianxing Jiang1, Xiaoqing Cai1.   

Abstract

An anti-EGFR nanobody was labeled at the C-terminus with a lysosome-sorting NPGY (Asn-Pro-Gly-Tyr) motif via sortase-mediated ligation to enhance the engagement of the clathrin-mediated endocytosis. The synergistic effects of NPGY motif and nona-arginine peptide were found to induce robust internalization and lysosomal trafficking, which in turn improved anti-tumor activity of an antibody-drug conjugate.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32108212     DOI: 10.1039/d0ob00265h

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  2 in total

Review 1.  Antibody-Drug Conjugates Targeting the Human Epidermal Growth Factor Receptor Family in Cancers.

Authors:  Jinfeng Yu; Tong Fang; Chengyu Yun; Xue Liu; Xiaoqing Cai
Journal:  Front Mol Biosci       Date:  2022-02-28

Review 2.  Targeted protein degradation: mechanisms, strategies and application.

Authors:  Lin Zhao; Jia Zhao; Kunhong Zhong; Aiping Tong; Da Jia
Journal:  Signal Transduct Target Ther       Date:  2022-04-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.